Abstract
Graft-versus-host disease (GVHD) is a complication of allogeneic hematopoietic stem cell transplantation with high morbidity and mortality. Extracorporeal photopheresis (ECP) is an effective therapy for treating medication-refractory GVHD, however, there is scant evidence of whether ECP can be safely performed in patients weighing less than 15 kg. Here, we report the implementation of a successful protocol to perform ECP in a 21-month-old, 10.6 kg female with medication-refractory GVHD. Our initial ECP treatment resulted in significant hemolysis that was most likely mechanical. After procedural adjustments that included modifying the anticoagulation dose and whole blood:anticoagulant ratio, as well as whole blood processing time, the patient tolerated future procedures safely without hemolysis or other adverse events. With appropriate technical modifications, we provide a framework for safely performing ECP in children less than 15 kg.
Original language | English (US) |
---|---|
Pages (from-to) | 571-573 |
Number of pages | 3 |
Journal | Journal of Clinical Apheresis |
Volume | 32 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2017 |
Externally published | Yes |
Keywords
- adverse event
- apheresis
- graft-versus-host disease
- hemolysis
- pediatric intensive care unit
ASJC Scopus subject areas
- Hematology